These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23714420)

  • 1. Phthalates in the NICU: is it safe?
    Fischer CJ; Bickle Graz M; Muehlethaler V; Palmero D; Tolsa JF
    J Paediatr Child Health; 2013 Sep; 49(9):E413-9. PubMed ID: 23714420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hair as an alternative matrix to assess exposure of premature neonates to phthalate and alternative plasticizers in the neonatal intensive care unit.
    Cleys P; Panneel L; Bombeke J; Dumitrascu C; Malarvannan G; Poma G; Mulder A; Jorens PG; Covaci A
    Environ Res; 2023 Nov; 236(Pt 2):116712. PubMed ID: 37482128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ongoing exposure to endocrine disrupting phthalates and alternative plasticizers in neonatal intensive care unit patients.
    Panneel L; Cleys P; Poma G; Ait Bamai Y; Jorens PG; Covaci A; Mulder A
    Environ Int; 2024 Apr; 186():108605. PubMed ID: 38569425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants.
    Green R; Hauser R; Calafat AM; Weuve J; Schettler T; Ringer S; Huttner K; Hu H
    Environ Health Perspect; 2005 Sep; 113(9):1222-5. PubMed ID: 16140631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cumulative risk assessment of phthalates exposure in preterm neonates.
    Al-Saleh I; Elkhatib R; Alnuwaysir H; Aldhalaan H; Binmanee A; Hawari A; Alhazzani F; Jabr MB
    Int J Hyg Environ Health; 2023 Mar; 248():114112. PubMed ID: 36657281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversy: neonatal exposure to plasticizers in the NICU.
    Pak VM; Nailon RE; McCauley LA
    MCN Am J Matern Child Nurs; 2007; 32(4):244-9. PubMed ID: 17667290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to di(2-ethylhexyl) phthalate in premature neonates in a neonatal intensive care unit in Taiwan.
    Su PH; Chang YZ; Chang HP; Wang SL; Haung HI; Huang PC; Chen JY
    Pediatr Crit Care Med; 2012 Nov; 13(6):671-7. PubMed ID: 22596068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health risks posed by use of Di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review.
    Tickner JA; Schettler T; Guidotti T; McCally M; Rossi M
    Am J Ind Med; 2001 Jan; 39(1):100-11. PubMed ID: 11148020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit.
    Calafat AM; Needham LL; Silva MJ; Lambert G
    Pediatrics; 2004 May; 113(5):e429-34. PubMed ID: 15121985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic Effects of Di-2-ethylhexyl Phthalate: An Overview.
    Rowdhwal SSS; Chen J
    Biomed Res Int; 2018; 2018():1750368. PubMed ID: 29682520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to reduce DEHP in your NICU: a plan of simple steps to promote change.
    Pak VM; Briscoe V; McCauley LA
    Neonatal Netw; 2006; 25(6):447-9. PubMed ID: 17163006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure-- an update and latest results.
    Koch HM; Preuss R; Angerer J
    Int J Androl; 2006 Feb; 29(1):155-65; discussion 181-5. PubMed ID: 16466535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prenatal phthalate exposure on thyroid hormone levels, mental and psychomotor development of infants: The Hokkaido Study on Environment and Children's Health.
    Minatoya M; Naka Jima S; Sasaki S; Araki A; Miyashita C; Ikeno T; Nakajima T; Goto Y; Kishi R
    Sci Total Environ; 2016 Sep; 565():1037-1043. PubMed ID: 27261429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of di(2-ethylhexyl)phthalate-containing infusion systems increases the risk for cholestasis.
    von Rettberg H; Hannman T; Subotic U; Brade J; Schaible T; Waag KL; Loff S
    Pediatrics; 2009 Aug; 124(2):710-6. PubMed ID: 19651587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phthalates and critically ill neonates: device-related exposures and non-endocrine toxic risks.
    Mallow EB; Fox MA
    J Perinatol; 2014 Dec; 34(12):892-7. PubMed ID: 25357096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The teratogenicity and behavioral teratogenicity of di(2-ethylhexyl) phthalate (DEHP) and di-butyl phthalate (DBP) in a chick model.
    Abdul-Ghani S; Yanai J; Abdul-Ghani R; Pinkas A; Abdeen Z
    Neurotoxicol Teratol; 2012; 34(1):56-62. PubMed ID: 22019469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phthalate exposure in the neonatal intensive care unit].
    Fischer Fumeaux CJ; Stadelmann Diaw C; Palmero D; M'Madi F; Tolsa JF
    Arch Pediatr; 2015 Feb; 22(2):203-10. PubMed ID: 25554670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adverse cardiac effects of Di(2-ethylhexyl)phthalate and Bisphenol A.
    Posnack NG
    Cardiovasc Toxicol; 2014 Dec; 14(4):339-57. PubMed ID: 24811950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive and developmental toxicity of phthalates.
    Lyche JL; Gutleb AC; Bergman A; Eriksen GS; Murk AJ; Ropstad E; Saunders M; Skaare JU
    J Toxicol Environ Health B Crit Rev; 2009 Apr; 12(4):225-49. PubMed ID: 20183522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal phthalate exposure: epigenetic changes leading to lifelong impact on steroid formation.
    Martinez-Arguelles DB; Papadopoulos V
    Andrology; 2016 Jul; 4(4):573-84. PubMed ID: 27044004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.